top of page


In today's marketplace, providing patient support services via a HUB is a market access reality for virtually all specialty products.

For many, it may seem logical simply to replicate the service models of industry-leading HUBs. But the reality is that a manufacturer’s approach to HUB design should be just as unique as the product and its patient and prescriber populations.

Designed for pharma and biotech patient support, brand, and market access teams, this webinar and whitepaper explore a variety of factors to consider when choosing between insourced, outsourced, and hybrid HUB models, including:

  • Characteristics of each model

  • Advantages & disadvantages of each model

  • Key requirements

  • Considerations for:

    • Program design

    • Technology & data

    • Legal/regulatory/compliance

    • Human resources

    • Training & quality

    • Facilities

    • Operations

  • Timelines 

  • Cost differences

Pharmaceutical and Biotech Consultancy Services in the USA and Europe

Register to View Webinar and Read the Whitepaper

bottom of page